State of the Science Summit - Gynecologic Cancers: Chaired Mario M. Leitao, Jr., MD, FACOG, FACS

Commentary
Article

In Partnership With:

State of the Science Summit - Gynecologic Cancers: Chaired Mario M. Leitao, Jr., MD, FACOG, FACS

Speakers

  • Claire Friedman, MD | Memorial Sloan Kettering Cancer Center
  • Rachel Grisham, MD | Memorial Sloan Kettering Cancer Center
  • Roisin O’Cearbhaill, MD | Memorial Sloan Kettering Cancer Center
  • Chrisann Kyi, MD | Memorial Sloan Kettering Cancer Center
  • Maria Rubinstein, MD | Memorial Sloan Kettering Cancer Center

Topics

  • Navigating PARP Inhibitors in Ovarian Cancer
  • Case Presentation: Maintenance Therapy In Ovarian Cancer
  • ADCs and New Targets in Ovarian Cancer
  • Updates in Endometrial Cancer
  • Case Presentation Endometrial Cancer
  • FIGO 2023 Endometrial Staging: Hit or Miss?

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Clinicians referring a patient to MSK can do so by visiting msk.org/refer, emailing referapatient@mskcc.org, or by calling 833-315-2722.
Related Videos
PAOLA-1: A Review of Progression-Free Survival and 5-Year Follow-up Overall Survival Analysis: Exploratory Post-Hoc Analysis by Clinical Risk of Relapse
Ramez N. Eskander, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO
Abdulrahman Sinno, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center
A panel of 5 experts on renal cell carcinoma
Chandler H. Park, MD, an expert on renal cell carcinoma
Amin Nassar, MD
Saad Z. Usmani, MD, MBA, FACP, FASCO, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center
Related Content
Ramez N. Eskander, MD, gynecologic oncologist, assistant professor, obstetrics, gynecology, and reproductive sciences, Moores Cancer Center, the University of California, San Diego Health

Pembrolizumab Plus Chemo Could Represent a New SOC in Advanced/Recurrent Endometrial Cancer

April 25th 2024
Article
Saad Z. Usmani, MD, MBA, FACP, FASCO, hematologist-oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center

FDA Approval Insights: Cilta-Cel in R/R Myeloma After at Least 1 Prior Line of Therapy

April 22nd 2024
Podcast
Mansoor Raza Mirza, MD, chief oncologist, Rigshospitalet — Copenhagen University Hospital

Dostarlimab/Chemo Receives FDA Priority Review for Expanded Indication in Endometrial Cancer

April 24th 2024
Article
Bradley J. Monk, MD, FACOG, FACS; Paolo Tarantino, MD

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

January 11th 2024
Podcast
Saad Z. Usmani, MD, MBA, FACP, FASCO, of Memorial Sloan Kettering Cancer Center

Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma

April 22nd 2024
Article
Idalid Franco, MD, MPH, director of Equity Access and Inclusion in the Department of Radiation Oncology at Brigham and Women’s Hospital and an instructor at Harvard Medical School, both in Boston, Massachusetts

Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer

April 20th 2024
Article